BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//London Global Cancer Week - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.lgcw.org.uk
X-WR-CALDESC:Events for London Global Cancer Week
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Etc/GMT
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T090000
DTEND;TZID=Etc/GMT:20241113T100000
DTSTAMP:20241109T105455Z
CREATED:20240729T210107Z
LAST-MODIFIED:20241109T105455Z
UID:10000229-1731488400-1731492000@www.lgcw.org.uk
SUMMARY:Oral cancer - causes\, early detection and prevention
DESCRIPTION:Register\nThis upcoming London Global Cancer Week (LGCW) C3 will be joined by Professor Warnakulasuriya – emeritus professor of Oral Medicine and Experimental Pathology at King’s College London – to discuss oral cancer\, it’s causes\, detection and prevention. \nAbout the speaker: \nProfessor Warnakulasuriya is an emeritus professor of Oral Medicine and Experimental Pathology at King’s College London\, UK and was the Chairman of the Oral Medicine Division at King’s College Hospital and at Guy’s Hospital\, London from 2005 -2015. He has made major contributions in cancer epidemiology\, oral medicine and experimental pathology. He is the Director of the WHO Collaborating Centre for Oral Cancer. Professor Warnakulasuriya received the IADR Distinguished Scientist Award in Oral Medicine and Pathology in 2014\, IADR Distinguished Scientist Award in Global Oral Health in 2022. He was elected a Fellow of King’s College London (FKC) for sustained and significant contributions to the College. He holds the Honorary Life Membership of the BSOM and International Association for Oral Pathologists. \nWhy oral cancer: \nOral cancer is the 13th most common cancer worldwide. Despite\, oral cancer being so prevalent and untreated dental caries (tooth decay) being the most common health condition according to the Global Burden of Disease 2019\, oral health is still often overlooked. Oral cancer is largely preventable and shares risk factors with other NCDs\, with tobacco and alcohol among the leading causes. C3 has long recognised the importance of tackling oral diseases including oral cancer through prevention and early detection as part of our mission to address NCDs. In fact\, since 2022 C3 have been working alongside Colgate\, the Commonwealth Nurses and Midwives Federation (CNMF)\, and the World Continuing Education Alliance (WCEA) as part of Colgate Bright Smiles\, Bright Futures\, to raise awareness about the importance of oral health for nurses and midwives and elevate the need for oral health education in practice. Learn more about C3’s oral health programmes.
URL:https://www.lgcw.org.uk/event/the-link-between-oral-health-and-cancer/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/C3-Collaborating.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T093000
DTEND;TZID=Etc/GMT:20241113T110000
DTSTAMP:20241112T234347Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241112T234347Z
UID:10000208-1731490200-1731495600@www.lgcw.org.uk
SUMMARY:Data on ALL\, Hodgkins and Wilms from Partner countries - improvement over time.
DESCRIPTION:Register\nThe Global Child Cancer subgroup of the Children’s Cancer and Leukaemia Group is made up of paediatric oncology doctors\, nurses and allied health professionals. Several paediatric oncology units have links with partner units in developing countries which have been present for many years. At this years London Cancer week we will present survival data on three key tumour types Leukaemia\, Hodgkins disease and Wilms tumour treatment highlighting the improvements that have happened over time. We will then discuss how data collection can be improved and what are the barriers to data collection.
URL:https://www.lgcw.org.uk/event/data-on-all-hodgkins-and-wilms-from-partner-countries-improvement-over-time/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/CCLG-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T110000
DTEND;TZID=Etc/GMT:20241113T120000
DTSTAMP:20241112T234347Z
CREATED:20241017T074508Z
LAST-MODIFIED:20241112T234347Z
UID:10000246-1731495600-1731499200@www.lgcw.org.uk
SUMMARY:Cancer Control through Tobacco Control in East Africa
DESCRIPTION:Register\nIn 2023\, Cancer Research UK and the Union for International Cancer Control launched a joint flagship programme in Kenya and Uganda with the aim of reducing the incidence of preventable cancers through effective tobacco control policies. Join us for this webinar during London Global Cancer Week\, hosted by Cancer Research UK\, to hear directly from Cancer Organisations working to build broad-based Tobacco Tax Coalitions who will be sharing their experiences\, challenges and opportunities in advocating for tobacco control\, and the importance of partnerships and coalition-building in these efforts\, as well as lessons from similar efforts supported by CRUK in in Sri Lanka and Nepal.  \nSpeakers: \nAlex Wright – Head of Global Policy & Programmes\, CRUK \nYannick Romero – Senior Knowledge & Advocacy Manager\, UICC \nPanellists: \nRachel Devotsu – McCabe Centre for Law and Cancer \nPhoebe Ongadi – Kenya Network of Cancer Organisation \nDennis Olodi – Uganda Cancer Society \nOlivia Stevens – KIVU International
URL:https://www.lgcw.org.uk/event/cancer-control-through-tobacco-control-in-east-africa/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/11/CRUK-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T120000
DTEND;TZID=Etc/GMT:20241113T130000
DTSTAMP:20250116T234104Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T234104Z
UID:10000209-1731499200-1731502800@www.lgcw.org.uk
SUMMARY:Opportunities to prevent liver cancer via urgent acceleration of viral hepatitis elimination
DESCRIPTION:Register\nWith almost a million new cases per year worldwide\, liver cancer is the sixth most common cancer globally\, with the highest rates of new cases and deaths seen in Asia and Africa. With the number of people diagnosed with or dying from liver cancer predicted to rise by 55% by 2040\, liver cancer will place an increasingly heavy burden on health systems across the world. \nThe two major hepatitis viruses—hepatitis B virus and hepatitis C virus—are oncogenic\, and viral hepatitis is a major cause of liver cancer. Despite the availability of an effective vaccine for hepatitis B and a cure for hepatitis C\, efforts to test and treat individuals for viral hepatitis and to prevent these infections are suboptimal. Ramping up these efforts is a critical component of cancer prevention that must be integrated and implemented into cancer prevention efforts globally. \nThe session provides the audience with the opportunity to learn more about the link between viral hepatitis and liver cancer\, and the key challenges facing efforts to eliminate viral hepatitis. The session will also focus on actionable aspects of hepatitis elimination with the end goal of preventing liver cancer.
URL:https://www.lgcw.org.uk/event/preventing-liver-cancer-through-eliminating-viral-hepatitis/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/Logos-for-LGCW.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T120000
DTEND;TZID=Etc/GMT:20241113T130000
DTSTAMP:20241027T123607Z
CREATED:20241021T201403Z
LAST-MODIFIED:20241027T123607Z
UID:10000249-1731499200-1731502800@www.lgcw.org.uk
SUMMARY:“Opportunities in Latin America for improving precision medicine in oncology”
DESCRIPTION:Register \nContext and Rationale \nCancer treatment has seen remarkable progress in recent years\, largely due to the advancements in precision medicine. This innovative approach enables personalized treatments that are tailored to the genetic and molecular characteristics of each patient’s tumor\, revolutionizing the way cancer is treated. With the help of precision diagnostics and genetic testing\, oncologists can now identify specific mutations that drive cancer growth\, paving the way for targeted therapies that are not only more effective but also less toxic than traditional treatments. These breakthroughs have led to significantly improved patient outcomes\, particularly in Europe and the United States\, where health systems have invested heavily in integrating these technologies into standard oncology care. \nIn regions like Europe and the U.S.\, organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology) have been at the forefront of research and clinical application of precision oncology. Experts in these organizations have helped shape the development and implementation of cutting-edge therapies\, as well as frameworks for precision diagnostics that have set a global benchmark. Their work has provided the foundation for clinical guidelines that support the integration of genetic profiling and biomarker-driven treatments in cancer care. These developments have not only enhanced treatment efficacy but also reduced the economic and physical burden of ineffective therapies. \nHowever\, while these advancements have become more commonplace in Europe and the U.S.\, Latin America faces significant challenges in replicating this progress. There are substantial gaps in infrastructure\, technology\, and funding across the region\, which hinder the adoption of precision medicine. Many countries lack the capacity for widespread genetic testing and molecular diagnostics\, and access to targeted therapies is often limited to a few specialized centers\, creating disparities in care. Additionally\, regulatory frameworks and reimbursement models are not yet fully equipped to support these innovations\, making it difficult for patients to benefit from the full spectrum of precision oncology. \nThis meeting aims to bring together the leading Cancer Institutes of Latin America\, along with key stakeholders and global experts\, to assess the current state of precision medicine in the region. The goal is to diagnose the situational challenges and explore the opportunities for improving cancer care through precision oncology. By drawing on the expertise of professionals involved in ASCO and ESMO\, the meeting will also serve as a platform to share international best practices\, promote collaboration\, and create actionable strategies for overcoming the region’s barriers to innovation. \nMeeting Objectives \n1. Assess the current state of precision medicine and diagnostics in the region: \nReview progress in using molecular diagnostics\, genetic testing\, and the implementation of targeted therapies across different cancer types in Latin America. Identify barriers to accessing these technologies. \n2. Share best practices in genetic testing and targeted therapies: \nFacilitate the exchange of successful experiences in using genetic testing to identify key mutations and selecting appropriate targeted therapies for each patient. \n3. Foster collaboration between cancer institutions: \nExplore cooperation among Cancer Institutes and other organizations to create networks that improve diagnostic capabilities\, share genetic data\, and enhance access to precision therapies. \n4. Develop regional strategies to improve access to precision medicine: \nDiscuss public policies\, funding\, and regulatory frameworks that will help increase the availability of genetic testing and access to targeted therapies \n5. Proposed Agenda Topics \n1. Overview of precision diagnostics and genetic testing in Latin America: \nThe current state of access to advanced molecular diagnostics\, genetic sequencing\, and laboratory capacities across the region. \n2. Advances in targeted therapies (target therapies): \nLatest innovations in the use of targeted therapies and how genetic tests help identify key biomarkers to personalize cancer treatment. \n3. Challenges and barriers to implementing genetic testing and access to precision therapies: \nIdentification of financial\, technological\, and regulatory obstacles that limit the use of genetic testing in clinical practice and access to targeted treatments. \n4. Collaboration and regional networks to enhance access to precision medicine: \nExploration of collaborative models between countries to improve early diagnosis\, data sharing\, and equitable access to targeted therapies. \n5. Public policy to promote precision medicine in oncology: \nProposals for policies that encourage investment in advanced diagnostic technologies and facilitate access to innovative treatments through subsidies\, insurance coverage\, and price regulation. \nExpected Outcomes \n• A current analysis of the state of precision medicine\, genetic testing\, and access to targeted therapies in Latin America. \n• Identification of the main barriers countries face in implementing precision diagnostics and using targeted therapies. \n• Proposals for inter-institutional collaboration to optimize the use of molecular diagnostic technologies and improve accessibility to personalized treatments. \n• Strategic recommendations to improve public policies that promote precision medicine in the region.
URL:https://www.lgcw.org.uk/event/opportunities-in-latin-america-for-improving-precision-medicine-in-oncology/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/10/selac-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T140000
DTEND;TZID=Etc/GMT:20241113T153000
DTSTAMP:20250116T234004Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T234004Z
UID:10000210-1731506400-1731511800@www.lgcw.org.uk
SUMMARY:Empowering Young Lives: Exploring the Global Impact\, Benefits\, and Insights of Xploro - An Innovative App Providing Essential Health Information on Childhood Cancer
DESCRIPTION:Register\nThe Xploro app uses gameplay and artificial intelligence to deliver essential health information to young patients and has been proven to strengthen coping mechanisms\, reduce anxiety\, improve procedural experiences and foster better long-term engagement with health services – all of which significantly improve health outcomes. \nThis session will feature a comprehensive demonstration of the Xploro app\, showcasing how it delivers critical health information to young patients in an engaging and accessible way. We will delve into the research underpinning the app’s impact\, highlighting its adaptation for use in low- and middle-income countries where World Child Cancer operates. \nAttendees will also hear firsthand experiences from child life specialists in Ghana and Malawi\, who will discuss the app’s impact on the children and families they support. This event is a unique opportunity to explore how innovative technology can enhance childhood cancer care and support the well-being of young patients globally.
URL:https://www.lgcw.org.uk/event/empowering-young-lives-exploring-the-global-impact-benefits-and-insights-of-xploro-an-innovative-app-providing-essential-health-information-on-childhood-cancer/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/world-child-cancer-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T143000
DTEND;TZID=Etc/GMT:20241113T153000
DTSTAMP:20250116T232912Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T232912Z
UID:10000211-1731508200-1731511800@www.lgcw.org.uk
SUMMARY:Achieving population-based palliative care: Learnings from Telangana\, India
DESCRIPTION:Register\nJoin Drs. Gayatri Palat and Gillian Fyles\, Mr. Swarup Immaraju\, and Ms. Vineela Rapelli as they discuss the road to achieving population-based palliative care in Telangana. \nAccess to effective and affordable palliative and end-of-life care for those with life-limiting diseases\, including cancer\, in lesser–resourced countries is limited\, resulting in a high burden of distress due to pain\, symptoms\, stigma\, isolation\, and financial compromise. \nThis presentation will address how Telangana\, a state in southern India\, moved from an absence of palliative care in the early 2000’s to a current\, internationally recognized palliative care program serving 38 million people in 33 administrative districts. The steps involved in creating this capacity and the key factors underlying successful implementation\, will be presented\, along with a roadmap for implementation that can be replicated elsewhere. We will describe how a collaboration between a state government and Indian and Canadian NGOs resulted in palliative care now being accessible to all\, including in the poorest and the remotest areas of the state.
URL:https://www.lgcw.org.uk/event/achieving-population-based-palliative-care-learnings-from-telangana-india/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.lgcw.org.uk/wp-content/uploads/2022/05/two-worlds-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T150000
DTEND;TZID=Etc/GMT:20241113T160000
DTSTAMP:20241112T234348Z
CREATED:20240807T202815Z
LAST-MODIFIED:20241112T234348Z
UID:10000232-1731510000-1731513600@www.lgcw.org.uk
SUMMARY:Introducing Cardio-Oncology: A Vital Addition for the Cancer Journey
DESCRIPTION:Register\nWith the increasing efficacy of cancer therapies concerns for quality of life continue to grow. Cardiovascular health is recognized as one of the most important areas for patients with cancer and survivors to pay attention to. This session will provide an overview of this developing field including some global perspectives.
URL:https://www.lgcw.org.uk/event/introducing-cardio-oncology-a-vital-addition-for-the-cancer-journey/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/08/international-Cardio-Oncology-Society.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T153000
DTEND;TZID=Etc/GMT:20241113T170000
DTSTAMP:20241112T234348Z
CREATED:20241004T081029Z
LAST-MODIFIED:20241112T234348Z
UID:10000243-1731511800-1731517200@www.lgcw.org.uk
SUMMARY:Impact of climate change in cancer care: experiences around the globe.
DESCRIPTION:Register\nThe webinar aims to increase awareness of the impact of climate change on patients and healthcare professionals;  and highlight ways in which the climate impacts of healthcare can be reduced\, and the role of clinical trials in this endeavour.  This involves discussion of the importance of climate change in cancer care\, testimonies from oncologists of the challenges for patients and providers in climate change impacted areas\, and solution focused talks on sustainability integration into patient care and clinical research. \nRunning Order: \n1. Welcome (Eduardo L. Cazap\, SLACOM) \n2.Introduction about climate change (Joan Schiller\, OUCH-I) \n3. Impact on patients and providers – \na. Experience from Brazil (Gustavo Gossling\, LACOG) \nb. Experience from Nigeria ( Olubukola Ayodele\, University Hospitals of Leicester NHS Trust\, UK ) \nc. Experience from The Philippines (Dr Roselle De Guzman\, Manila Central University-FDT Medical Foundation Hospital) \n4. Tool kits \na. Clinical trials (Lisa Fox\, The Institute of Cancer Research) \nb. Medical Oncology (Seamus O’Reilly\, Cancer Trials Ireland) \nc. Radiotherapy\, (Katie Lichter\, (University of California\, San Francisco\, USA)) \nd. Surgery\, (Shelley Hwang\, Duke University)
URL:https://www.lgcw.org.uk/event/impact-of-climate-change-in-cancer-care-experiences-around-the-globe-2/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/10/Logos-together-LGCW-Claire-Hopkins.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T160000
DTEND;TZID=Etc/GMT:20241113T170000
DTSTAMP:20241231T005840Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241231T005840Z
UID:10000213-1731513600-1731517200@www.lgcw.org.uk
SUMMARY:Every facility\, every country: SIOP Global Mapping of Paediatric Oncology Services
DESCRIPTION:Register\nThe SIOP Global Mapping Programme of Paediatric Oncology Services has the potential to benefit everyone\, especially the children\, adolescents\, and young adults for whom we care. Mapping allows us to know where care is being delivered\, by whom and with which resources. \nWe will present the current landscape of paediatric oncology services around the world and the benefits and challenges of mapping. Join us to learn about the power of mapping for professionals\, patients and families\, governments\, non-governmental organizations\, and other key stakeholders.
URL:https://www.lgcw.org.uk/event/every-facility-every-country-siop-global-mapping-of-paediatric-oncology-services/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/SIOP-global-mapping.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T160000
DTEND;TZID=Etc/GMT:20241113T170000
DTSTAMP:20241230T205652Z
CREATED:20240823T182243Z
LAST-MODIFIED:20241230T205652Z
UID:10000238-1731513600-1731517200@www.lgcw.org.uk
SUMMARY:Global Disparities in Supportive Care in Cancer\, one size does not fit all
DESCRIPTION:Register\nEducational Objectives: \n-Understand the differing definitions and issues related to healthcare disparities across regions of the world. \n-Analyse the different perspectives from global stakeholders regarding the most important issues related with cancer supportive care. \n-Apply the knowledge obtained form the webinar to better understand the way in which to evaluate the local disparities in supportive care in cancer and the possibilities to interact with other stakeholders to tackle these disparities.
URL:https://www.lgcw.org.uk/event/global-disparities-in-supportive-care-in-cancer-one-size-does-not-fit-all/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/MASCC-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T160000
DTEND;TZID=Etc/GMT:20241113T173000
DTSTAMP:20250120T212229Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250120T212229Z
UID:10000212-1731513600-1731519000@www.lgcw.org.uk
SUMMARY:Women\, Power\, and Cancer - NCI Session at LGCW 2024
DESCRIPTION:Register\nThe Lancet Commission on Women\, Power\, and Cancer addresses urgent questions at the intersection of social inequality\, cancer risk and outcomes\, and the status of women in society. A year out from the publication of the 2023 Commission report\, the NCI convenes this London Global Cancer Week session to review progress made and discuss plans for evaluation\, patient engagement\, and opportunities for further research.
URL:https://www.lgcw.org.uk/event/a-framework-for-monitoring-progress-at-the-intersection-of-women-power-and-cancer/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/NCI-event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T090000
DTEND;TZID=Etc/GMT:20241114T100000
DTSTAMP:20241113T235629Z
CREATED:20240708T230553Z
LAST-MODIFIED:20241113T235629Z
UID:10000214-1731574800-1731578400@www.lgcw.org.uk
SUMMARY:Creating a World Radiotherapy Awareness Day (WRAD) - Morning session
DESCRIPTION:Register\nIn this event we are bringing supporters for a World Radiotherapy Awareness Day (WRAD) together from all parts of the world (radiation oncology professionals of all types\, patients and carers\, society and industry representatives) to finalise the details for creating a WRAD to be officially launched in 2025. This dedicated day (extended over a week) will amplify advocacy efforts around the world in raising awareness of life-saving and life-improving radiotherapy (radiation therapy).  \nWe value everyone’s input to this session at which attendees will vote on the final date\, the inaugural theme and our new logo. We will share ideas for maximising impact from WRAD. Please join us in making history together!
URL:https://www.lgcw.org.uk/event/creating-a-world-radiotherapy-awareness-day-wrad/
LOCATION:Hybrid (In person and virtual)
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/WRAD-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T100000
DTEND;TZID=Etc/GMT:20241114T113000
DTSTAMP:20241113T235629Z
CREATED:20240708T230553Z
LAST-MODIFIED:20241113T235629Z
UID:10000215-1731578400-1731583800@www.lgcw.org.uk
SUMMARY:Investing in Cancer Prevention and Control in Low-and Middle-Income Countries including Small Island Developing States: A Strategic Multi-Country Dialogue.
DESCRIPTION:Register\nThe Commonwealth\, which represents over 30 per cent of the world’s population\, carries a substantial share of the global cancer incidence and mortality burden. Cancer rates in the Commonwealth have risen by 35% over the past decade\, with a further 35% increase in incidence of cancer predicted in the years leading up to 2030 and a 39% increase in cancer mortality. \nFor specific cancers like cervical cancer\, the burden is even higher. The Commonwealth carries 40 percent share of the global cervical cancer incidence burden\, and 43 percent of the global mortality burden. A report from the Daffodil Centre\, a world-leading research centre on cervical cancer control and policy revealed that co-ordinated efforts to meet the WHO 90-70-90 cervical cancer targets in Commonwealth Low-and Middle-Income countries (LMICs) have the potential to avert almost 40 million cases and save over 35 million lives within a century – alleviating more than half of the burden that these countries would otherwise bear.  \nThere is therefore a need for strengthened coordinated and collective action to accelerate Cancer control in the Commonwealth. It is for this reason that the Commonwealth Secretariat is organising a strategic multi-country dialogue on Cancer prevention and control centred around increasing investment on cancer control with a focus on LMICs including Small Island Developing States (SIDS).  \nThe Objectives are: \n   -To raise awareness of the current burden of Cancers in the Commonwealth and  \n    understand key challenges and roadblocks preventing Cancer prevention and control. \n  -To share national\, regional\, and Commonwealth-wide case studies and strategies to  \n    advance Cancer prevention and control efforts. \n  -To build a compelling case for increased investment for Cancer prevention and control in  \n    the Commonwealth. \n  – To share the Report of the Lancet Oncology Commission on Cancer in the  \n    Commonwealth. \nThis event which will take place during the commemoration of the London Global Cancer week (LGCW) will bring together all the 56 Commonwealth member countries to share experiences\, challenges\, and best practices partnerships for Cancer Control investments.  \nPartners and Stakeholders championing cancer control in the world will also have the opportunity during the event to share some multi-dimensional approaches and opportunities for investment in cancer which countries can tap into.  \nThe event will equally provide a platform for young people and people with lived experiences of Cervical cancer to share their views and call for action on investment in Cancer control in the Commonwealth. This event will be open to the general public for maximum participation.
URL:https://www.lgcw.org.uk/event/investing-in-cancer-prevention-and-control-in-low-and-middle-income-countries-including-small-island-developing-states-a-strategic-multi-country-dialogue/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/common-wealth-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T103000
DTEND;TZID=Etc/GMT:20241114T123000
DTSTAMP:20250116T231349Z
CREATED:20241023T121832Z
LAST-MODIFIED:20250116T231349Z
UID:10000250-1731580200-1731587400@www.lgcw.org.uk
SUMMARY:Spotlight on Radiotherapy: Essential standards for sustainable and quality radiotherapy services
DESCRIPTION:Register\nThe radiotherapy focused session will be an engaging discussion with the global community to examine the essential standards for radiotherapy service development and sustainability. The session will feature a diverse lineup of speakers who will address critical questions and share their expertise on sustaining funding for radiotherapy facilities\, each RT Essential Standard in detail\, and strategies for integrating radiotherapy in to policy. Following the presentations\, a panel discussion will provide further insights and encourage collaborative dialogue.
URL:https://www.lgcw.org.uk/event/spotlight-on-radiotherapy-essential-standards-for-sustainable-and-quality-radiotherapy-services-2/
LOCATION:The Library at Conway Hall
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/GCR-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T120000
DTEND;TZID=Etc/GMT:20241114T130000
DTSTAMP:20241113T235629Z
CREATED:20241018T174707Z
LAST-MODIFIED:20241113T235629Z
UID:10000248-1731585600-1731589200@www.lgcw.org.uk
SUMMARY:Quality Metrics in Cancer Surgery: Regional Perspectives
DESCRIPTION:Register\nEnsuring the delivery of safe\, timely\, high-quality\, and affordable cancer surgical care in the Global South requires an adequate number of well-trained surgeons.  \nBuilding sustainable\, contextually appropriate\, and resource-stratified educational and research platforms is essential for creating this workforce and delivering high-quality cancer care.  \nThis session will bring together experts to discuss the current situation\, highlight challenges\, and propose strategies for improvement.
URL:https://www.lgcw.org.uk/event/quality-metrics-in-cancer-surgery-regional-perspectives/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/08/IASO-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T130000
DTEND;TZID=Etc/GMT:20241114T140000
DTSTAMP:20241113T235629Z
CREATED:20240829T172848Z
LAST-MODIFIED:20241113T235629Z
UID:10000241-1731589200-1731592800@www.lgcw.org.uk
SUMMARY:Cancer Surgery: Who should do it? Global Perspectives
DESCRIPTION:Register\nEnsuring the delivery of timely\, safe\, and affordable surgical cancer care is dependent on the presence of an adequately trained and competent surgical cancer workforce. It is well-known that there is a major shortage of surgeons that are capable of delivering surgical cancer care on the global stage. In addition to the shortage\, there is also extreme variability in the training paradigms and practice patterns leading to inconsistency in the capabilities of the surgeon and thereby the care that is provided.  \nThis session will include speakers who will focus on the type of surgical workforce required to deliver high-quality cancer surgery\, pertaining to their region of the world.
URL:https://www.lgcw.org.uk/event/cancer-surgery-who-should-do-it-global-perspectives/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/07/gfcs-logo-2023.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T130000
DTEND;TZID=Etc/GMT:20241114T140000
DTSTAMP:20241113T235629Z
CREATED:20241011T175751Z
LAST-MODIFIED:20241113T235629Z
UID:10000244-1731589200-1731592800@www.lgcw.org.uk
SUMMARY:Addressing antimicrobial resistance (AMR) for better cancer care - the importance of effective antimicrobial stewardship
DESCRIPTION:Register\nPeople with cancer are more susceptible to infections due to the lowering of their immune defences. As many as one in five cancer patients undergoing treatment is hospitalized due to an infection and infections are the second leading cause of death for people living with cancer.  The emergence of drug-resistant pathogens is a grave threat to cancer care.  There is an urgent need to address the critical issue of AMR as it will roll back progress made to date in modern medicines\, including cancer treatment. The time to act is now. \nIn this regard\, the second UN high-level meeting on AMR took place on 26 September 2024\, where the political declaration on addressing AMR was adopted by Members States. At this meeting\, Member States committed to a set of actions to mitigate AMR across all sectors\, using a One Health approach that recognises the interconnectedness between human\, animal\, agriculture and environmental health. There are several commitments outlined under action on human health to effectively address AMR including focus on knowledge and awareness raising\, ensuring access to appropriate therapies\, effective stewardship and infection prevention and control (IPC) etc. Progress in these areas will have a positive impact on cancer care outcomes.  \nAll key stakeholders must come together to accelerate progress and implement actions to address AMR at national\, regional and global levels.  AMR is a complex and widespread issue that requires immediate and collaborative action.  \nIn this regard\, the London Global Cancer Week is an annual event that brings together all the relevant stakeholders and experts in the field. It is an ideal platform to bring together experts from the cancer and AMR fields to discuss what action needs to be taken to address this challenge.  \nObjective and expected results \nThe objective of this virtual dialogue is to emphasize the crucial role of effective antimicrobial stewardship (AMS) in promoting the responsible use of medications to manage infections\, ultimately contributing to improved outcomes in cancer care.
URL:https://www.lgcw.org.uk/event/addressing-antimicrobial-resistance-amr-for-better-cancer-care-the-importance-of-effective-antimicrobial-stewardship/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/10/uicc-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T140000
DTEND;TZID=Etc/GMT:20241114T153000
DTSTAMP:20241231T011137Z
CREATED:20241015T193448Z
LAST-MODIFIED:20241231T011137Z
UID:10000245-1731592800-1731598200@www.lgcw.org.uk
SUMMARY:An AORTIC dialogue with Africa CDC and the African Regional Office of WHO: Galvanising African cancer research and building a strong cancer workforce
DESCRIPTION:Register\nThe African Organisation for Research and Training in Cancer welcomes the opportunity to join the London Global Cancer Week platform to share perspectives on the policies and actions to drive cancer prevention and control along with African partners the African regional office of the World Health Organization and Africa CDC. Members of the AORTIC Executive Council\, education and research committees will lead the discourse with insights from international partners. We welcome AORTIC members\, current and future partners to join us in this four-part interactive discussion: \n1. Forging partnerships for meaningful political engagement in response to the growing \ncancer burden in Africa – perspectives from AORTIC President\, WHO AFRO and Africa CDC \n2. Panel discussion 1 \nGalvanising African cancer research\, building on the strengths of international partnerships – what will this take? \n3. Panel discussion 2 \nSteps to building and retaining strong cancer workforce – what will this take? \n4. Sharing of the AORTIC 2035 ambitions and partner reflections on the emerging leadership role of AORTIC.
URL:https://www.lgcw.org.uk/event/an-aortic-dialogue-with-africa-cdc-and-the-african-regional-office-of-who-galvanising-african-cancer-research-and-building-a-strong-cancer-workforce/
LOCATION:N/A
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2022/06/Aortic-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T160000
DTEND;TZID=Etc/GMT:20241114T170000
DTSTAMP:20250120T214013Z
CREATED:20240815T144222Z
LAST-MODIFIED:20250120T214013Z
UID:10000235-1731600000-1731603600@www.lgcw.org.uk
SUMMARY:Amuse-bouche: The Lancet Commission on Cancer and Health System
DESCRIPTION:Register\nThe rising cancer burden demands innovative solutions that leverage\, develop\, and enhance synergies across various systems. The future of cancer control and health system strengthening is interconnected\, personalized\, adaptable to new knowledge\, and essential to achieving universal health coverage.  \nThe panel will cover the following key topics:  \n– The Cancer And Health Systems Approach: Highlight how addressing cancer-specific challenges can simultaneously strengthen health systems. \n– Cancer Burden: Focusing on redefining our understanding of its complexity and how this should shape desired outcomes. We will introduce a global collaborative study capturing people’s perspectives of the cancer burden using an interactive online dashboard.  \n– A Value Approach to Investing in Cancer: Analyse the global and multi-dimensional costs and benefits of reducing the cancer burden with data from a pilot study in Mexico and Peru for select cancers covering out-of-pocket expenses and the value of alleviating suffering.  \nLearning objectives  \nThis panel will invite attendees to:  \n– Think critically about the cancer burden and how it is measured as a starting point to better understand the challenges and benefits of designing more effective person-centered strategies.  \n– Reflect on the benefits of expanding cancer control and the impact on health systems\, accelerating progress toward universal health coverage.  \n– Share elements of a strengthened case for investment in cancer control\, by incorporating the experiences of individuals with cancer into the cost-benefit analysis.
URL:https://www.lgcw.org.uk/event/amuse-bouche-the-lancet-commission-on-cancer-and-health-system/
LOCATION:Virutal
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/lancet-commission.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T170000
DTEND;TZID=Etc/GMT:20241114T180000
DTSTAMP:20250116T232029Z
CREATED:20240819T191931Z
LAST-MODIFIED:20250116T232029Z
UID:10000237-1731603600-1731607200@www.lgcw.org.uk
SUMMARY:Cancer control in the face of climate change
DESCRIPTION:Register\nAchieving effective cancer control internationally will be increasingly challenged by climate change and environmental damage. Efforts to improve cancer prevention\, detection\, and care\, are already impacted by extreme weather events and rising pollution. Any efforts to mitigate these effects will need to include steps by health care systems to reduce their carbon footprint\, since health care accounts for roughly 4-5% of all carbon emissions globally. These challenges are greatest in countries with less well developed health systems. In this session we will bring together experts to discuss the ways in which cancer policy and health systems can adapt to and mitigate the impact of climate change. \nhttps://docs.google.com/document/d/1Hg19J4TNlC6FxEp5PK_rXu6_5ngbylbDFOY1BSwMiVg/edit?usp=sharing
URL:https://www.lgcw.org.uk/event/cancer-control-in-the-face-of-climate-change/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/ouch-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T170000
DTEND;TZID=Etc/GMT:20241114T180000
DTSTAMP:20250116T231124Z
CREATED:20241030T121111Z
LAST-MODIFIED:20250116T231124Z
UID:10000251-1731603600-1731607200@www.lgcw.org.uk
SUMMARY:Understanding the economic and regulatory challenges of cancer prevention to unlock future opportunities
DESCRIPTION:Register\nAn estimated 22 million people worldwide will have cancer in 2030. Policy goals of reducing cancer mortality often default to a discourse of advancing therapeutic strategies\, strongly supported by the pharmaceutical industry. However\, the impact of cancer therapeutics on survival remains limited. \nA cancer diagnosis and its treatment\, successful or not\, impose a heavy burden on patients and their loved ones. Preventing cancers from arising would reduce mortality and the negative social and psychological impact of this disease. \nCurrent estimates suggest that at least 30-50% of cancers are preventable with opportunities to go further by better understanding the underlying mechanisms of cancer genesis and risk. In this shared Cancer Research UK and Consilium Scientific webinar\, experts in broad aspects of health policy and economics will discuss the historical funding limitations of cancer prevention research compared to therapeutics. \nWhat are the current regulatory and economic barriers to advancing cancer prevention? Do we need novel models of health economics to promote cancer prevention? What are the challenges of behavioural and interventional prevention strategies? How can they be overcome? \nJoin us at this webinar focused on highlighting the growing global importance of cancer prevention and the vast opportunities ahead.
URL:https://www.lgcw.org.uk/event/understanding-the-economic-and-regulatory-challenges-of-cancer-prevention-to-unlock-future-opportunities/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.lgcw.org.uk/wp-content/uploads/2024/10/Understanding-economic-regulatory-challenges-of-cancer-prevention-to-unlock-future-opportunities-1.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T180000
DTEND;TZID=Etc/GMT:20241114T190000
DTSTAMP:20241113T235629Z
CREATED:20241030T124334Z
LAST-MODIFIED:20241113T235629Z
UID:10000252-1731607200-1731610800@www.lgcw.org.uk
SUMMARY:Creating a World Radiotherapy Awareness Day (WRAD) - Evening session
DESCRIPTION:Register\nIn this event we are bringing supporters for a World Radiotherapy Awareness Day (WRAD) together from all parts of the world (radiation oncology professionals of all types\, patients and carers\, society and industry representatives) to finalise the details for creating a WRAD to be officially launched in 2025. This dedicated day (extended over a week) will amplify advocacy efforts around the world in raising awareness of life-saving and life-improving radiotherapy (radiation therapy).  \nWe value everyone’s input to this session at which attendees will vote on the final date\, the inaugural theme and our new logo. We will share ideas for maximising impact from WRAD. Please join us in making history together!
URL:https://www.lgcw.org.uk/event/creating-a-world-radiotherapy-awareness-day-wrad-evening-session/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/WRAD-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241115T090000
DTEND;TZID=Etc/GMT:20241115T180000
DTSTAMP:20241111T231509Z
CREATED:20240708T230553Z
LAST-MODIFIED:20241111T231509Z
UID:10000216-1731661200-1731693600@www.lgcw.org.uk
SUMMARY:Cancer Health Disparities: Understanding the inequalities conundrum
DESCRIPTION:Register – Online \nThis Cancer Health Disparities Day program aims at raising awareness\, educating the community\, and fostering collaboration among healthcare professionals\, policymakers\, researchers\, and community organizations to address cancer health disparities. Cancer disparities continue to disproportionately affect underserved and marginalized populations\, leading to higher mortality rates\, reduced access to care\, and poorer outcomes. The proposed program will serve as a platform to discuss these disparities\, share knowledge\, and develop actionable strategies to reduce inequities in cancer care. \nThe event will include keynote presentations\, panel discussions\, interactive workshops\, and community engagement sessions. It will highlight current research on cancer disparities\, success stories from communities that have implemented effective interventions\, and opportunities for stakeholders to collaborate on future initiatives. The event is expected to attract approximately 100 participants\, including healthcare providers\, researchers\, public health professionals and community leaders. \nDate: 15th November 2024\nLocation: Terrace Pavilion\, House of Commons\, London\, United Kingdom\nObjectives: Understanding the very complex problem of cancer health inequalities and striving to explore ways to reduce the impact and find lasting solutions. \nSchedule\nDownload the Agenda \n8:30 AM – 9:20 AM: Registration and Breakfast \nMorning Session\n9:20 AM – 9:25 AM: Welcome/Introductions \nSpeaker: Dr Olubukola Ayodele\, Chair\, Steering Committee \n9:25 AM – 9:30 AM: Opening Remarks \nSpeakers: Dr Katie Wakeham / Dr Susannah Stanway\nChairpersons: Prof Richard Sullivan and Dr Katie Wakeham \n9:30 AM – 9:50 AM: Keynote Address \n\nSpeaker: Prof Ophira Ginsburg\, National Cancer Institute-Centre for Global Health\nTopic: “Overview of Cancer Health Disparities: Current State and Future Directions”\n\n9:50 AM – 10:10 AM: Session 1 – Epidemiology of Cancer Disparities \n\nSpeaker: Prof Nirmala Bhoo Pathy\nTopic: “Determinants of Cancer Disparities – Data-Driven Insights from South East Asia”\n\n10:10 AM – 10:30 AM: Session 2 – Genetic and Biological Factors \n\nSpeaker: Prof Nick James\nTopic: “Genetic Predispositions and Cancer Risk in Minority Populations” (Lancet Commission on Prostate Cancer)\n\n10:30 AM – 10:50 AM: Session 3 – Access to Care \n\nSpeaker: Prof Charlotte Coles\nTopic: “Challenges and Solutions for Equitable Breast Cancer Prevention and Early Detection” (Lancet Commission on Breast Cancer)\n\n10:50 AM – 11:10 AM: Session 4 – Policy and Advocacy \n\nSpeaker: Rob Yates\, London School of Economics / London School of Hygiene and Tropical Medicine\nTopic: “Universal Health Coverage”\n\nMid-Morning Session\nChairperson: Dr Aruni Ghose \n11:10 AM – 11:50 AM: Session 5 – E-Poster Presentations \n\nZeeshan Arif: “Impact of Postcode on Treatment for Metastatic Hormone-Sensitive Prostate Cancer: May the Odds Be Ever in Your Favour” (UK)\nGebrekirstos Hagos: “Patterns of Cancer in Needle Hospital” (Somaliland)\nLin Cheng: “Assessment of Knowledge and Attitudes Towards Cancer Among Ethnic Chinese Immigrants – A Community-Based Collaborative Survey in Glasgow” (UK)\nHarenthri Rajah: “Unequal Burden: Disparities in Financial Toxicity Following Cancer in an Upper Middle-Income Nation Making Good Progress Towards Universal Health Coverage” (Malaysia)\nLucy Mitchinson: “Accessing Lung Cancer Care in Urban and Rural Settings: Development of a Patient Engagement Tool” (UK)\nFavour Okoye: “Model of Hospice Care Service Delivery for Patients with Advanced Cancer in a Resource-Limited Setting” (Nigeria)\nHaleema Aslam: “Improving Uptake and Access to the NHS Breast Screening Programme for Minority Ethnic Women in Leicester” (UK)\nChris Chukwunyere: “Enhancing HPV Vaccine Uptake: CSO’s Role in Cervical Cancer Prevention in Nigeria” (Nigeria)\n\n11:50 AM – 12:20 PM: Panel Discussion \nModerator: Prof Pat Price \nPanel Members: \n\nMs Dawn Butler MP\, House of Commons\nMr Ben Simms\, CEO of Tropical Health Education Trust\nDr Paul Chilwesa\, Head of Policy\, Population Health and Health Systems Strengthening\, Roche Africa\nProf Ophira Ginsburg\, National Cancer Institute of Global Health\nProf Jean-Marc Bourque\, Chair\, Canadian Global Oncology Group\n\n12:20 PM – 1:00 PM: Lunch Break \nAfternoon Session\nChairpersons: Mr Neil Ranasinghe and Rev Dr Kofi Adesi Kyei \n1:00 PM – 1:20 PM: Session 6 – Pharmacy (Virtual) \n\nSpeaker: Dr Irene Weru\, Honorary Lecturer\, Department of Pharmacy\, University of Nairobi\, Kenya\nTopic: “The Role of the Pharmacist in Tackling Cancer Health Disparities”\n\n1:20 PM – 1:40 PM: Session 7 – Paediatric Cancer Disparities \n\nSpeaker: Dr Jessica Bate\, Southampton Children’s Hospital\nTopic: “Challenges and Solutions in Paediatric Oncology”\n\n1:40 PM – 2:00 PM: Session 8 – Patient Navigation and Support Services (Virtual) \n\nSpeaker: Daniel Sherman\, Lacks Cancer Center\, Grand Rapids\, Michigan\nTopic: “Improving Patient Outcomes Through Navigation Services”\n\n2:00 PM – 2:20 PM: Session 9 – Survivorship and Quality of Life \n\nSpeaker: Dilnasheen Safdar\, Director of Nursing and Infection Control\, National Institute of Blood Diseases\, Lahore Campus\, Pakistan\nTopic: “Addressing Quality of Life Issues in Cancer Survivors” (Nursing Perspective)\n\n2:20 PM – 2:40 PM: Vanessa Moss Prize \nPresented by: Mr Ben Simms\, CEO of THET\nWinner: Mr Masood Moghul\, The Royal Marsden NHS Foundation Trust\nTopic: “The Man Van—Using Mobile Targeted Case-Finding to Address Health Inequalities in Prostate Cancer & Other Health Conditions” \n2:40 PM – 3:00 PM: Coffee Break \nMid-Afternoon Session\nChairpersons: Dr Solomon Kibudde and Prof Annie Young \n3:00 PM – 3:20 PM: Session 10 – Rural Health Disparities \n\nSpeaker: Dr Warren Phipps\, University of Washington\nTopic: “Cancer Care Challenges in Rural Areas”\n\n3:20 PM – 3:40 PM: Session 11 – Urban Health Disparities \n\nSpeaker: Keith Morgan\, Associate Director of Black Health Equity\, PCUK\nTopic: “Championing Black Health Equity in Prostate Cancer”\n\n3:40 PM – 4:00 PM: Session 12 – Technology and Telemedicine \n\nSpeaker: Prof Laurence Court\, MD Anderson Cancer Center\nTopic: “Leveraging Technology to Reduce Cancer Disparities”\n\n4:00 PM – 4:20 PM: Session 13 – Global Health Perspectives (Virtual) \n\nSpeaker: Dr Nwamaka Lasebikan\, NICRAT\, Nigeria\nTopic: “Cancer Disparities in Low and Middle-Income Countries”\n\n4:20 PM – 4:40 PM: Session 14 – Future Directions in Research \n\nSpeaker: Dr Tanimola Martins\, University of Exeter\nTopic: “Emerging Research Areas in Cancer Health Disparities”\n\n4:40 PM – 4:45 PM: Summary Comments\nSpeaker: Prof David Collingridge\, Vice President\, Lancet; Editor-in-Chief\, Lancet Oncology \n4:45 PM – 4:55 PM: Closing Remarks\nSpeaker: Ms Dawn Butler MP \n4:55 PM – 5:00 PM: Vote of Thanks\nSpeaker: Dr Olubukola Ayodele\, Chair\, Steering Committee \n  \n\nSponsoring Companies and Exhibitors\nThe meeting is supported by sponsorship from exhibiting companies – they have had no input into\, or influence over\, the agenda or content. The exhibition will be located at the Terrace Pavilion along with refreshments during the day. \nSponsors\nPlatinum Level: AstraZeneca \n \nGold Level: PCUK \n \nSilver Level: Merck \n \nSpeakers\nDownload full speaker biographies here.. \n\nOphira Ginsburg\nDr. Ginsburg is a medical oncologist and global women’s health researcher with 20 years of experience in global cancer prevention and control…\nNirmala Bhoo Pathy\nProf. Nirmala Bhoo-Pathy\, an epidemiologist and physician\, champions well-being for cancer patients and their families…\nNick James\nProfessor James is Professor of Prostate and Bladder Cancer Research at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust\, London…\nCharlotte Coles\nCharlotte Coles is Professor of Breast Cancer Clinical Oncology at the University of Cambridge…\nRob Yates\nMr. Rob Yates is a political health economist specializing in universal health coverage (UHC) and progressive health financing…\nKeith Morgan\nKeith is the Associate Director of Black Health Equity at Prostate Cancer UK…\nDaniel Sherman\nDan Sherman has been in the field of financial navigation services for oncology patients since 2008…\nDilnasheen Safdar\nDilnasheen Safdar is the Director of Nursing at the National Institute of Blood Diseases and Bone Marrow Transplantation\, Lahore\, Pakistan…\nNwamaka Lasebikan\nDr. Nwamaka Lasebikan is a clinical oncologist and clinical investigator/Director of Oncology at the University of Nigeria Teaching Hospital…\nJessica Bates\nDr. Jessica Bates is a Consultant Paediatric Oncologist at Southampton Children’s Hospital…\nWarren Phipps\nWarren Phipps is an Associate Professor at the University of Washington and Associate Member at the Fred Hutchinson Cancer Center…\nLaurence Court\nProf. Laurence Court is the Service Chief of Breast Physics and director of radiation physics global oncology cancer network…\nKathleen Schmeler\nDr. Kathleen Schmeler is a Professor of Gynecologic Oncology at The University of Texas MD Anderson Cancer Center…\nDario Trapani\nDario Trapani\, MD\, is a medical oncologist at the European Institute of Oncology IRCCS Milan…\nTanimola Martins\nTanimola Martins is a Senior Research Fellow at the University of Exeter Medical School…\nJean-Marc Bourque\nDr. Bourque specializes in the treatment of breast cancers with a special interest in health services research…\nZainab Shinkafi-Bagudu\nDr. Zainab Shinkafi-Bagudu is a global expert in cancer care…\nPat Price\nProfessor Pat Price trained in general medicine in Cambridge and in oncology at the Royal Marsden Hospital…\nRichard Sullivan\nProfessor Richard Sullivan is a Professor of Cancer & Global Health at King’s College London…\nNeil RanasingheNeil Ranasinghe is the parent of a survivor of childhood cancer and has been involved with global and UK-based cancer organisations for nearly 20 years…\nOlubukola Ayodele\nDr. Olubukola Ayodele is a Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust (UHL)\, UK…\n\nDr. Susannah Stanway: Honorary consultant medical oncologist at the Royal Marsden Hospital\, specializing in breast cancer and global cancer care\, co-convener of London Global Cancer Week\, and advocate for reducing cancer outcome disparities.\n\nDr. Katie Wakeham: NHS-trained Clinical Oncology Consultant focused on enhancing global radiotherapy access through collaboration\, author of a ten-year vision for UK radiotherapy\, and co-chair of London Global Cancer Week.
URL:https://www.lgcw.org.uk/event/cancer-health-disparities-tackling-the-inequalities-conundrum/
LOCATION:Terrace Pavillion\, The House of Commons
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/health-disparities-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251124T090000
DTEND;TZID=Europe/London:20251124T103000
DTSTAMP:20251123T100636Z
CREATED:20250922T065003Z
LAST-MODIFIED:20251123T100636Z
UID:10000294-1763974800-1763980200@www.lgcw.org.uk
SUMMARY:2025 China-UK Anti-Cancer Summit
DESCRIPTION:Register\nOnline Webinar. Each country shares its own side of the story and progress..
URL:https://www.lgcw.org.uk/event/2025-china-uk-anti-cancer-summit-3/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2025/09/CACA_round_680x500_padded60.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251124T120000
DTEND;TZID=Europe/London:20251124T130000
DTSTAMP:20251123T100836Z
CREATED:20251110T170911Z
LAST-MODIFIED:20251123T100836Z
UID:10000316-1763985600-1763989200@www.lgcw.org.uk
SUMMARY:Hope Beyond Borders\, voices from the MENA Childhood Cancer Survivors Meet-Up united. The “Thrive together” regional Camp Survivors virtual Reunion
DESCRIPTION:Register\nThrive Beyond Borders brings together childhood cancer survivors from the MENA region who joined the first regional Thrive Together Camp. This virtual session offers an inspiring look at life after cancer through the voices of young survivors who continue to reshape the meaning of strength\, resilience\, and hope in a region marked by challenges and deep human connection. They will share personal stories\, reflecting on the bonds\, confidence\, and skills gained during the camp\, and how these moments guide them as they build their futures. Their experiences reveal not only the difficulties of treatment but also the vibrant and meaningful lives that follow recovery. \nThe session raises global awareness about survivorship needs in low and middle-income countries\, calls for stronger long-term care and psychosocial support\, and inspires stakeholders to invest in life beyond cancer as much as in treatment. Open to audiences worldwide\, it invites policymakers\, health professionals\, NGOs\, and advocates to hear directly from survivors and support a growing movement for comprehensive survivorship care.
URL:https://www.lgcw.org.uk/event/hope-beyond-borders-voices-from-the-mena-childhood-cancer-survivors-meet-up-united-the-thrive-together-regional-camp-survivors-virtual-reunion/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/CCCL.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251124T120000
DTEND;TZID=Europe/London:20251124T133000
DTSTAMP:20251215T162251Z
CREATED:20251103T220019Z
LAST-MODIFIED:20251215T162251Z
UID:10000315-1763985600-1763991000@www.lgcw.org.uk
SUMMARY:Patient Navigation - Building Global Momentum for a Vital Resource Linking Patients and Caregivers Throughout the Cancer Continuum
DESCRIPTION:Register\nPatient navigation was developed to ensure support in accessing comprehensive\, equitable\, and patient-centered cancer care services and is generally defined as an individualized intervention to break down barriers to quality and timely care across the cancer continuum. \nThis 90-minute session will explore how diverse global efforts are working towards incorporating patient navigation as a core\, sustained cancer care service. \nSpeakers will include: \nAnu Agrawal\, MD\, Vice President\, Global Cancer Support\, American Cancer Society \nRaymond Chan\, RN\, PhD\, Deputy Vice Chancellor\, Research\, Flinders University and Lead\, Global Initiative to Advance Cancer Navigation for Better Outcomes (GINO) \nMary Nyangasi\, MD\, Lead\, Global Breast Cancer Initiative\, World Health Organization \nKristie McComb\, MPH\, Managing Director\, Global Patient Support\, American Cancer Society \nHanna Serry\, Baheya Foundation\, Egypt \nPatricia Chacón\, MD\, Hospital General San Juan de Dios\, Guatemala \nFollowed by a Panel Discussion Among Speakers and Q&A Session \nPlease join us!
URL:https://www.lgcw.org.uk/event/https-drive-google-com-openid1qeycveud2u3h7p7wqzvi2kjhmatftqpu/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2025/11/ThreeLogos_onWhite_680x500.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251124T130000
DTEND;TZID=Europe/London:20251124T143000
DTSTAMP:20251123T102606Z
CREATED:20250919T210752Z
LAST-MODIFIED:20251123T102606Z
UID:10000285-1763989200-1763994600@www.lgcw.org.uk
SUMMARY:World-wide trends in patterns of care and survival from cancer: VENUSCANCER and CONCORD-4
DESCRIPTION:Register\nCONCORD is an ambitious global public health programme for the long-term surveillance of population-based cancer survival. In 2018\, the third cycle of CONCORD (CONCORD-3) documented wide global differences in survival trends over the period 2000-2014\, for most cancers in adults\, and for brain tumours and haematological malignancies in children. \nThe VENUSCANCER project\, embedded in the CONCORD programme\, aims to examine whether global differences in survival for three of the most common cancers in women are attributable to differences in disease biology between populations\, or patterns of care\, or socio-economic status. Cancer registries were invited to submit data for a single year of complete incidence during 2015-2018\, for which availability and completeness of high-resolution variables (e.g.\, stage\, staging procedures\, biomarkers\, treatment) were highest. VENUSCANCER offered financial support to 11 registries in LMIC to enable collection of these data. We will present indicators of consistency with clinical treatment guidelines\, derived from over 250\,000 anonymised individual records of women diagnosed with breast\, cervical or ovarian cancer between 2015 and 2018 in 39 countries\, including 15 LMICs. \nWe will also present preliminary trends in age-standardised 5-year net survival from CONCORD-4\, which has received anonymised individual records for over 95 million adults diagnosed with one of 22 cancers\, and more than 600\,000 children diagnosed with any cancer during the 30 years 1990-2019. Data were submitted by 381 population-based cancer registries in 75 countries world-wide.
URL:https://www.lgcw.org.uk/event/world-wide-trends-in-patterns-of-care-and-survival-from-cancer-venuscancer-and-concord-4/
LOCATION:The London School of Hygiene and Tropical Medicine\, 41 Keppel Street\, Bloomsbury\, United Kingdom
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2025/09/CONCORD_EU_ERC_1200.png
GEO:51.5207651;-0.129472
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=The London School of Hygiene and Tropical Medicine 41 Keppel Street Bloomsbury United Kingdom;X-APPLE-RADIUS=500;X-TITLE=41 Keppel Street:geo:-0.129472,51.5207651
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251124T140000
DTEND;TZID=Europe/London:20251124T150000
DTSTAMP:20251216T225517Z
CREATED:20250929T145208Z
LAST-MODIFIED:20251216T225517Z
UID:10000299-1763992800-1763996400@www.lgcw.org.uk
SUMMARY:Building Leadership Capacity Across Global Oncology
DESCRIPTION:Register\nLeadership skills\, critical but often overlooked in oncology training\, are essential for global cancer control by improving healthcare delivery\, policy advocacy\, education\, research\, and community engagement. Leadership training enables cancer professionals to improve clinical care\, advocate for better policies\, and foster global collaborations\, driving more equitable and effective cancer care. Featuring the innovative Global Oncology Leadership Development (GOLD)\, the Young Leaders in Cancer and Biosciences Oncology Leadership Development (BOLD) programs\, this session highlights how structured learning programs and international collaboration are shaping the next generation of cancer care leaders. \nThrough real-world examples and alumni experiences\, attendees will gain insight into how leadership capacity in cancer is being built across diverse regions. The session will delve into regional challenges and opportunities for capacity-building\, lessons learned from the design of existing curricula\, and scope for further international expansion. They will also learn about how institutions can support future leaders\, and strategies for fostering equity and sustainability in leadership programs.
URL:https://www.lgcw.org.uk/event/building-leadership-capacity-across-global-oncology/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2025/09/CGON_680x500_75.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251124T150000
DTEND;TZID=Europe/London:20251124T163000
DTSTAMP:20251216T214941Z
CREATED:20250905T201106Z
LAST-MODIFIED:20251216T214941Z
UID:10000281-1763996400-1764001800@www.lgcw.org.uk
SUMMARY:Strengthening Pediatric Oncology Care in Nigeria: Global Action\, Local Impact
DESCRIPTION:Register\nNigeria is making significant strides in strengthening pediatric cancer care through strategic collaboration between health institutions\, government stakeholders\, and international partners. \nHosted by The Dorcas Cancer Foundation\, this session will give participants an in-depth overview of the country’s pediatric oncology landscape. The discussion will cover recent advances in policy development\, capacity building\, research\, and patient-centered support. \nExpert speakers\, including leaders from Nigerian hospitals\, government agencies\, and international pediatric oncology partners\, will share experiences from ongoing initiatives\, collaborative projects\, and lessons learned. \nThe session offers participants valuable opportunities for collaboration and shared best practices. Participants will leave equipped with actionable knowledge to enhance their programs\, contribute to sustainable improvements in pediatric oncology\, and support children and families affected by cancer.
URL:https://www.lgcw.org.uk/event/strengthening-pediatric-oncology-care-in-nigeria-global-action-local-impact/
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2025/09/DorcasCancerFoundation.png
END:VEVENT
END:VCALENDAR